PHENOXYBENZAMINE HYDROCHLORIDE
Details
- Status
- Prescription
- First Approved
- 2012-07-16
- Routes
- ORAL
- Dosage Forms
- CAPSULE
PHENOXYBENZAMINE HYDROCHLORIDE Approval History
What PHENOXYBENZAMINE HYDROCHLORIDE Treats
2 indicationsPHENOXYBENZAMINE HYDROCHLORIDE is approved for 2 conditions since its original approval in 2012. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Pheochromocytoma
- Hypertension
Drugs Similar to PHENOXYBENZAMINE HYDROCHLORIDE
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
PHENOXYBENZAMINE HYDROCHLORIDE FDA Label Details
ProIndications & Usage
Phenoxybenzamine hydrochloride capsules are indicated in the treatment of pheochromocytoma, to control episodes of hypertension and sweating. If tachycardia is excessive, it may be necessary to use a beta -blocking agent concomitantly.
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.